Quantcast

Latest Eisai Co. Ltd. Stories

2011-11-18 00:20:01

Tokyo, Nov 18, 2011 - (JCN Newswire) - Eisai Co. Ltd announced today that it has entered into a Japan co-promotion agreement with Novartis Pharma K.K.

2011-09-07 20:20:01

Enters Collaborative Development Agreement with SFJ Pharmaceuticals for Anticancer Agent E7080 (lenvatinib) Tokyo, Sept 7, 2011 - (JCN

2011-09-01 04:20:02

Looks to Expand Global Epilepsy Product Portfolio Tokyo, Sept 1, 2011 - (JCN Newswire) - Eisai Co., Ltd.

2011-08-29 12:20:01

Tokyo, Aug 29, 2011 - (JCN Newswire) - Abbott Japan Co., Ltd. and Eisai Co., Ltd.

2011-08-10 04:35:01

Tokyo, Aug 10, 2011 - (JCN Newswire) - Eisai Co., Ltd.

2011-07-19 12:35:02

Tokyo, July 19, 2011 - (JCN Newswire) - Eisai Co., Ltd. today announced the launch of its novel anticancer agent Halaven(R) in Japan for the treatment of inoperable or recurrent breast cancer.

2011-04-22 04:35:01

Tokyo, Apr 22, 2011 - (JCN Newswire) - Eisai Co., Ltd. (TSE: 4523) announced today that it has received approval to market its novel anticancer Halaven(R) Injection 1mg (eribulin mesylate) in Japan for the treatment of inoperable and recurrent breast cancer.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related